UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients

Multiple sclerosis, 2023-01, Vol.29 (1), p.63-73

2023

Volltextzugriff (PDF)

Swiss recommendations for the diagnosis, management and follow-up of post-COVID condition in primary care medicine (2023)

Swiss medical weekly, 2023-09, Vol.153 (9), p.3468

2023

Volltextzugriff (PDF)

Hypogammaglobulinämie und Multiple Sklerose: Ein übersehener Zusammenhang?

Therapeutische Umschau, 2022-08, Vol.79 (6), p.285-288

2022

Volltextzugriff (PDF)

The Role of Neurorehabilitation in Post-COVID-19 Syndrome

Clinical and translational neuroscience, 2023-06, Vol.7 (2), p.13

2023

Volltextzugriff (PDF)

Accelerated Course of Alveolar Echinococcosis After Treatment With Steroids in a Patient With Autoimmune Encephalitis

Curēus (Palo Alto, CA), 2021-10

2021

Volltextzugriff (PDF)

Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events

Therapeutic advances in neurological disorders, 2024-01, Vol.17, p.17562864241237853-17562864241237853

2024

Volltextzugriff (PDF)

Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study

Therapeutic advances in neurological disorders, 2021, Vol.14, p.17562864211030664-17562864211030664

2021

Volltextzugriff (PDF)

Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age

Therapeutic advances in neurological disorders, 2019-05, Vol.12, p.1756286419843450-1756286419843450

2019

Volltextzugriff (PDF)

Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis

Journal of translational autoimmunity (Online), 2022-01, Vol.5, p.100172-100172, Article 100172

2022

Volltextzugriff (PDF)

Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course

Therapeutic advances in neurological disorders, 2019, Vol.12, p.1756286419878340-1756286419878340

2019

Volltextzugriff (PDF)

Long-term evaluation of NEDA-3 status in relapsing-remitting multiple sclerosis patients after switching from natalizumab to fingolimod

Therapeutic advances in neurological disorders, 2018-01, Vol.11, p.1756286418791103-1756286418791103

2018

Volltextzugriff (PDF)

Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies

Therapeutic advances in neurological disorders, 2021, Vol.14, p.17562864211016641-17562864211016641

2021

Volltextzugriff (PDF)

Persisting lymphopenia and dimethyl fumarate: A clinical commentary

Multiple sclerosis, 2021-07, Vol.27 (8), p.1309-1310

2021

Volltextzugriff (PDF)

Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19

Journal of central nervous system disease, 2022-05, Vol.14, p.11795735221102727-11795735221102727

2022

Volltextzugriff (PDF)

Recommendations for the Treatment of Multiple Sclerosis in Family Planning, Pregnancy and Lactation in Switzerland: Immunotherapy

Clinical and translational neuroscience, 2024-08, Vol.8 (3), p.26

2024

Volltextzugriff (PDF)

Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients

Vaccines (Basel), 2022-06, Vol.10 (6), p.922

2022

Volltextzugriff (PDF)

Pathological cerebrospinal fluid protein concentration and albumin quotient at relapse predicts short-term disability progression in multiple sclerosis: a retrospective single center observational study

Therapeutic advances in neurological disorders, 2020, Vol.13, p.1756286420975909-1756286420975909

2020

Volltextzugriff (PDF)

Primäre ZNS-Vaskulitis: Eine Übersicht

Therapeutische Umschau, 2022-06, Vol.79 (5), p.247-253

2022

Volltextzugriff (PDF)

Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge

Neurology : neuroimmunology & neuroinflammation, 2021-05, Vol.8 (3)

2021

Volltextzugriff (PDF)

Anti‐neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia—a case report and review of the literature

European journal of neurology, 2023-04, Vol.30 (4), p.1135-1147

2023

Volltextzugriff (PDF)

Multiple sclerosis as a model to investigate SARS‐CoV‐2 effect on brain atrophy

CNS neuroscience & therapeutics, 2023-02, Vol.29 (2), p.538-543

2023

Volltextzugriff (PDF)

Anti‐kelchlike protein 11 antibody‐associated encephalitis: Two case reports and review of the literature

European journal of neurology, 2023-06, Vol.30 (6), p.1801-1814

2023

Volltextzugriff (PDF)

Multidimensional phenotyping of the post‐COVID‐19 syndrome: A Swiss survey study

CNS neuroscience & therapeutics, 2022-12, Vol.28 (12), p.1953-1963

2022

Volltextzugriff (PDF)

Age‐dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross‐sectional study

CNS neuroscience & therapeutics, 2019-04, Vol.25 (4), p.527-531

2019

Volltextzugriff (PDF)

Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort

CNS neuroscience & therapeutics, 2021-04, Vol.27 (4), p.426-438

2021

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(36)
Buchkapitel
(4)

Sprache

Englisch
(38)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients

Swiss recommendations for the diagnosis, management and follow-up of post-COVID condition in primary care medicine (2023)

Hypogammaglobulinämie und Multiple Sklerose: Ein übersehener Zusammenhang?

The Role of Neurorehabilitation in Post-COVID-19 Syndrome

Accelerated Course of Alveolar Echinococcosis After Treatment With Steroids in a Patient With Autoimmune Encephalitis

Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events

Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study

Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age

Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis

Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course

Long-term evaluation of NEDA-3 status in relapsing-remitting multiple sclerosis patients after switching from natalizumab to fingolimod

Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies

Persisting lymphopenia and dimethyl fumarate: A clinical commentary

Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19

Recommendations for the Treatment of Multiple Sclerosis in Family Planning, Pregnancy and Lactation in Switzerland: Immunotherapy

Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients

Pathological cerebrospinal fluid protein concentration and albumin quotient at relapse predicts short-term disability progression in multiple sclerosis: a retrospective single center observational study

Primäre ZNS-Vaskulitis: Eine Übersicht

Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge

Anti‐neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia—a case report and review of the literature

Multiple sclerosis as a model to investigate SARS‐CoV‐2 effect on brain atrophy

Anti‐kelchlike protein 11 antibody‐associated encephalitis: Two case reports and review of the literature

Multidimensional phenotyping of the post‐COVID‐19 syndrome: A Swiss survey study

Age‐dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross‐sectional study

Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort

Suchergebnisse filtern